Aldagen, Inc
Get Full AccessDescription
- Aldagen is a wholly-owned subsidiary of Cytomedix, Inc (BB:CMXI). The Aldagen subsidiary develops proprietary regenerative cell therapies in the vascular area. These cell therapeutics consist of a specific population of stem cells from a patients own bone marrow. Aldagen isolates these cells, which are typically less than 1% of all cells in bone marrow, using our proprietary technology. Based on preclinical studies and our clinical trials to date, Aldagen believes these cell populations have the potential to promote the regeneration of multiple types of cells and tissues, including the growth of new blood vessels, a process known as angiogenesis. Aldagen's product candidates are ALD-301 for the treatment of critical limb ischemia, ALD-201 for the treatment of ischemic heart failure and ALD-401 for the treatment of ischemic stroke.
-
Headquarters:2810 Meridian Parkway Suite 148, Durham, North Carolina, United States
More -
Phone Number: +1 919-484-2571
-
Website: https://www.aldagen.com
-
Employees:6
-
Revenue:$1 - 10M
-
Legal Name:Aldagen, Inc
-
Aldagen, Inc's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Aldagen, Inc
-
Where are Aldagen, Inc's Headquarters?
Aldagen, Inc's Headquarters are in 2810 Meridian Parkway Suite 148,Durham,North Carolina,United States
-
What is Aldagen, Inc's phone number?
Aldagen, Inc's phone number is +1 919-484-2571
-
What is Aldagen, Inc's official website?
Aldagen, Inc's official website is https://www.aldagen.com
-
What is Aldagen, Inc's Revenue?
Aldagen, Inc's revenue is $1 - 10M
-
What is Aldagen, Inc's NAICS code?
Aldagen, Inc's NAICS code is 541713
-
How many employees are working in Aldagen, Inc
Aldagen, Inc has 6 employees
-
What is Aldagen, Inc's Industry?
Aldagen, Inc is in the industry of Biotechnology
-
Who is Aldagen, Inc's CEO?
Aldagen, Inc's CEO is Tom Amick

